According to MarketBeat.com, Charles River Laboratories International has an average rating of “Moderate Buy” and an average target price of $188.29. Get Charles River Laboratories International alerts:View Our Latest Report on Charles River Laboratories InternationalCharles River Laboratories International Stock Down 0.4%Shares of NYSE:CRL traded down $0.74 during midday trading on Monday, reaching $167.07. Charles River Laboratories International has a fifty-two week low of $91.86 and a fifty-two week high of $203.01. Charles River Laboratories International Company Profile(Get Free Report)Charles River Laboratories International, Inc provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. Featured ArticlesReceive News & Ratings for Charles River Laboratories International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Charles River Laboratories International and related companies with MarketBeat.com's FREE daily email newsletter.